90 Surfactant Lung Lavage and Inhaled Nitric Oxide in The Treatment of Meconium Aspiration Syndrome 2- Influence on Duration of Mechanical Ventilation, Inhalation of Nitric Oxide, Hospitalization, and Complications

J Gadzinowski,K Kowalska,M Szymankiewicz
DOI: https://doi.org/10.1203/00006450-200409000-00113
IF: 3.953
2004-09-01
Pediatric Research
Abstract:The most severe clinical problem which coexist with the meconium aspiration syndrome/MAS/is persistent pulmonary hypertension/PPHN/.The aim of our study was to evaluate the efficacy of treatment of MAS for selected clinical parameters. The designed therapeutic approach consisted of surfactant lung lavage/SLL/and surfactant instillation together with Nitric Oxide inhalation/iNO/. The study population was randomized into two groups: group A/n= 7/treated with SLL, surfactant instillation and iNO, and group B/n= 6/treated with surfactant instillation and iNO. Criteria for inclusion: maturity >35 weeks of gestation, time after delivery < 24hours, presence of fluid containing meconium below vocal cords, respiratory insufficiency demanding mechanical ventilation/Fi0240%/, radiological changes, and echocardiographic features of pulmonary hypertension.Method: SLL was performed with natural surfactant solution (Survanta, Ross Abbott Laboratories) in concentration of 5mg of phospholipids/1 ml 0,9% NaCl, a dose of 15ml of solution per 1 kg. A dose of 100 mg of Surfactant per 1 kg was applied. The initial NO dose was 20 ppm. The parameters analyzed: duration of IMV, duration of iNO, duration of hospitalization, air leaks and deaths.Results: (mean value ± b SD). Duration of IMV: GROUP A- 6,6± b 2,5days vs. GROUP B- 7,3± b 1,7days (NS). Duration of iNO: GROUP A- 2,9 ± b1,5days vs. GROUP B- 3,5 ± b1,3days (NS). Duration of hospitalization: GROUP A-16,4 ± b5,4 days vs. GROUP B- 19, ± b2,9 days (NS). Air leaks: GROUP A- 0 vs. GROUP B- 2 (NS). Deaths: GROUP A- 0; GROUP B- 2 (NS).Conclusions: The associated treatment of SLL with natural surfactant solution together with iNO in the therapy of severe meconium aspiration syndrome with persistent pulmonary hypertension does not have a significant influence on the reduction of duration of IMV, iNO and the hospitalization time and on the reduction of occurrence of complications and deaths.
pediatrics
What problem does this paper attempt to address?